- Hematology in Clinical Practice
- Search Author Details
Author Details
Lech-Marańda, Ewa, Poland
-
Vol 7, No 1 (2016) - CASE REPORT
The efficacy of lenalidomide in the patient with plasma cell myeloma coexisting with myelodysplatic syndrome associated with isolated del 5q–
Abstract PDF (Polish) HTML (Polish) -
Vol 8, No 2 (2017) - CASE REPORT
Coexistence of plasma cell dyscrasias and myelodysplastic syndrome — study of cases and review of literature
Abstract PDF (Polish) HTML (Polish) -
Vol 8, No 2 (2017) - ORIGINAL ARTICLE
Assessment of nutritional status in patients with myeloid and lymphoid neoplasms, using the PG-SGA score
Abstract PDF (Polish) HTML (Polish) -
Vol 8, No 2 (2017) - ORIGINAL ARTICLE
Incidence and disease prevalence for hematologic neoplasms in Poland (2009–2015) as determined on the analysis of the National Health Fund data used in the project ‘Maps of healthcare needs — database of systemic and implementation analyses’
Abstract PDF (Polish) HTML (Polish) -
Vol 8, No 3 (2017) - CASE REPORT
Lymphocytic meningitis after intrathecal liposomal cytarabine in a patient with acute lymphoblastic leukemia
Abstract PDF (Polish) HTML (Polish) -
Vol 9, No 4 (2018) - IN THE OPINION OF THE CONSULTANT
Zdaniem konsultanta
Details PDF (Polish) -
Vol 10, Supp. C (2019) - CASE REPORT
The role of brentuximab vedotin in the treatment of patients with refractory/relapsed Hodgkin lymphoma based on two case reports
Abstract PDF (Polish) -
Vol 10, No 2 (2019) - CASE REPORT
The role of brentuximab vedotin in the treatment of patients with refractory/relapsed Hodgkin lymphoma based on two case reports
Abstract PDF (Polish) -
Vol 10, No 4 (2019) - IN THE OPINION OF THE CONSULTANT
Zdaniem konsultanta
Details PDF (Polish) -
Vol 11, No 2 (2020) - CASE REPORT
Venetoclax monotherapy before second allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia
Abstract PDF (Polish) -
Vol 11, No 2 (2020) - IN THE OPINION OF THE CONSULTANT
Zdaniem konsultanta
Details PDF (Polish) -
Vol 11, No 4 (2020) - EXPERTS' POSITION
Consensus of the Polish Lymphoma Research Group experts on the management of relapsed or refractory classical Hodgkin lymphoma in 2020
Abstract PDF (Polish) -
Vol 11, No 4 (2020) - CASE REPORT
Difficulties in the management of a patient with acute myeloid leukaemia and high mutant allelic ratio FLT3-ITD — refractoriness to the standard induction therapy along with midostaurin
Abstract PDF (Polish) -
Vol 13, No 1 (2022) - CASE REPORT
Efficacy of midostaurin combined with intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation in a patient with NPM1 and FLT3-TKD mutated acute myeloid leukaemia with clinical high-risk features
Abstract PDF -
Vol 13, No 1 (2022) - CASE REPORT
Midostaurin in the treatment of a patient with acute myeloid leukaemia with FLT3-TKD mutation and NPM1 mutation
Abstract PDF -
Vol 12, Supp. D (2021) - CASE REPORT
Difficulties in the management of a patient with acute myeloid leukaemia and high mutant allelic ratio FLT3-ITD — refractoriness to the standard induction therapy along with midostaurin
Abstract PDF -
Vol 12, Supp. D (2021) - CASE REPORT
Midostaurin in the treatment of patient with acute myeloid leukemia with FLT3-TKD mutation and NPM1 mutation
Abstract PDF -
Vol 12, Supp. D (2021) - CASE REPORT
Effectiveness of combined therapy with midostaurin and standard chemotherapy and high dose chemotherapy with allogeneic stem cell transplantation in high risk acute myeloid leukemia with FLT3-TKD and NPM1 mutations
Abstract PDF -
Vol 14 (2023): Continuous Publishing - CASE REPORT
Ruxolitinib as a primary treatment for multiple myeloma in a patient with primary myelofibrosis? A case report and the review of the literature
Abstract PDF -
Vol 14 (2023): Continuous Publishing - CASE REPORT
Coexistence of chronic lymphocytic leukemia and NK/T lymphoma of the nasopharynx in a patient treated with ibrutinib
Abstract PDF
Important: This website uses cookies. More >>
The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl